Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Addressing underrepresentation in Parkinson's research is crucial for better treatments and understanding.

Air Vice-Marshal Sir Ralph Jackson significantly advanced dialysis technology in the UK.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Many transgender men on testosterone therapy experience hair loss.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Diagnosing osteoporosis in transgender people is challenging due to unclear guidelines and hormone treatment effects.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

A reliable method was developed to measure dutasteride in tablets accurately and consistently.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

Finasteride may lower cholesterol and slow heart disease progression.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Feminizing hormone therapy increases kidney filtration rate.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.